OSA
99
9
12
61
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Research Maturity
61 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.0%
1 terminated out of 99 trials
98.4%
+11.8% vs benchmark
6%
6 trials in Phase 3/4
16%
10 of 61 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 61 completed trials
Clinical Trials (99)
Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea (OASIS)
Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized Cardiac Patients
Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation
Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP
Inspire Singapore Study
Obstructive Sleep Apnea (OSA), Oral Frailty, Dysphagia, Continuous Positive Airway Pressure (CPAP)
Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease?
MEA DPA Hypoxic Event Reductions
The Effect of Interval Exercise on Functional Outcomes in Veterans With COPD and OSA
Mandibular Advancement Device and Changes in Nocturia
Ultrasonographic of Diaphragmatic Function in Obstructive Sleep Apnea
Impact of Muscle Training Device on Non-Severe OSA
Automated Manual Lymphatic Drainage Therapy to Improve Glymphatic Function in OSA Patients
Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea
Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)
COPD Circuit Exercise
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Effects of Lemborexant as a Treatment for Moderate-to-severe OSA Patients With Low Arousal Threshold
The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease